An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos)

Summary Objective To determine the efficacy and safety of oral dihydroartemisinin–piperaquine (DP, ArtekinTM) in the treatment of uncomplicated Plasmodium falciparum malaria in southern Laos. Methods An open, randomized clinical trial of oral artesunate–mefloquine (AM) vs. DP in 220 patients with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Tropical medicine & international health 2006-08, Vol.11 (8), p.1157-1165
Hauptverfasser:	Mayxay, M., Thongpraseuth, V., Khanthavong, M., Lindegårdh, N., Barends, M., Keola, S., Pongvongsa, T., Phompida, S., Phetsouvanh, R., Stepniewska, K., White, N. J., Newton, P. N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adolescent Adult Antimalarials - administration & dosage Antimalarials - adverse effects Artemisinins - administration & dosage Artemisinins - adverse effects artemisinin‐based combination therapy Biological and medical sciences Child Clinical trials combinaison thérapeutique à base d'artemisinine dihidroartemisina‐piperaquina dihydroartemisinin–piperaquine dihydroartémisinine‐pipéraquine Drug Therapy, Combination Female General aspects Human protozoal diseases Humans Infectious diseases Laos Laos - epidemiology Malaria Malaria, Falciparum - drug therapy Malaria, Falciparum - epidemiology Male Medical sciences Medical treatment Mefloquine - administration & dosage Mefloquine - adverse effects Parasitemia - drug therapy Parasitemia - epidemiology Parasitic diseases Plasmodium falciparum Protozoal diseases Quinolines - administration & dosage Quinolines - adverse effects Quinolines - blood Recurrence Sesquiterpenes - administration & dosage Sesquiterpenes - adverse effects terapia de combinación basada en artemisina Treatment Failure Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!